📰 Jack Cox News
Page 6 - Jack Cox News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jack Cox. Real-time updates on events, politics, business and more.
June 9, 2023
Detailed price information for Biogen Inc (BIIB-Q) from The Globe and Mail including charting and trades.
June 9, 2023
FinancialContent fully hosted finance channel
June 8, 2023
TOKYO and CAMBRIDGE, Mass., June 8, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Eisai has submitted a marketing authorization application for lecanemab (brand
June 2, 2023
Logisticsmanager.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from logisticsmanager.com Daily Mail and Mail on Sunday newspapers.
May 22, 2023
TOKYO, May 20, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Eisai has submitted a Marketing Authorization Application (MAA) for lecanemab, an investigational anti-amyloid
May 16, 2023
TOKYO and CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts
May 16, 2023
TOKYO and CAMBRIDGE, Mass., May 16, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Health Canada has accepted a New Drug Submission (NDS) for lecanemab (brand name in the
April 28, 2023
Seán Cox’s life was changed forever when he was brutally assaulted outside Anfield five years ago. But he and his wife are determined not to dwell on the past
April 25, 2023
Strong progress toward three potential launches in 2023; Company reports first quarter 2023 results and reaffirms full year 2023 guidance First... | April 25, 2023
April 25, 2023
FDA granted accelerated approval of QALSODY based on a reduction of neurofilament, a marker of neurodegeneration1Superoxide dismutase 1 -amyotrophic lateral sclerosis is a devastating, uniformly... | April 25, 2023